Facial Injectables | Medtech 360 | Market Analysis | US | 2017
The US market for facial injectables will surpass $2 billion by 2025, driven primarily by high patient demand, including from emerging patient groups such as men and younger patients. High ASPs have also made this market particularly lucrative; however, new product releases and competitors will increase downward price pressure.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for facial injectables in the US across a 10-year period.